Synthesis of Tetrahydropyrrolo/indolo[1,2-a]pyrazines by Enantioselective Hydrogenation of Heterocyclic Imines
文献类型：期刊论文
| 作者 | Chen Mu-Wang1; Zhou Yong-Gui1; Hu Shu-Bo1,2; Zhai Xiao-Yong1 |
| 刊名 | ACTA CHIMICA SINICA
 |
| 出版日期 | 2018-02-15 |
| 卷号 | 76期号:2页码:103-106 |
| ISSN号 | 0567-7351 |
| 关键词 | Asymmetric Hydrogenation Heterocyclic Imines Tetrahydropyrrolo/indolo[1 2-a]Pyrazines |
| DOI | 10.6023/A17110476 |
| 文献子类 | Article |
| 英文摘要 | 1,2,3,4-Tetrahydropyrrolo[1,2-a]pyrazines are an important motif due to their biological activities and widely existing in natural products. Notably, the substituent and the absolute configuration are important for the medicinal efficacy. Thus, the synthesis of chiral tetrahydropyrrolo[1,2-a]pyrazines has attracted much attention of scientists. Most synthetic methods utilized chiral starting materials or auxiliaries. Kinetic resolution was an alternative way to give chiral tetrahydropyrrolo[ 1,2-a]pyrazines. The first catalytic asymmetric synthetic method was developed in 2011 by Li and Antilla through a chiral phosphoric acid-catalyzed asymmetric intramolecular aza-Friedel-Crafts reaction of aldehydes with N-aminoethylpyrroles in high enantiocontrol level. Subsequently, the sequential aerobic oxidation-asymmetric intramolecular aza-Friedel-Crafts reaction between N-aminoethylpyrroles and benzyl alcohols for the synthesis of tetrahydropyrrolo[ 1,2-a]pyrazines was realized using chiral bifunctional heterogeneous materials composed of Au/Pd nanoparticles and chiral phosphoric acids. The asymmetric hydrogenation as an efficient way has been successfully applied to synthesize the kind of chiral amines. In 2012, Our group achieved the asymmetric hydrogenation of 1-substituted pyrrolo[1,2-a]pyrazines via a substrate activation strategy. Recently, we reported the direct asymmetric hydrogenation of 3-substituted pyrrolo[1,2-a]pyrazines in up to 96% ee values. Considering their impressive significance, herein, we successfully hydrogenated 3,4-dihydropyrrolo[1,2-a]pyrazines and 3,4-dihydroindolo[1,2-a]pyrazines with up to 99% yield and 95% ee. The reaction features mild condition, high enantioselectivity and high atom-economy. The typical procedure for asymmetric hydrogenation is as follows: A mixture of [Ir(COD) Cl](2) (3.0 mg, 0.0045 mmol) and the ligand Cy-WalPhos (6.6 mg, 0.0099 mmol) was stirred in toluene (1.0 mL) at room temperature for 5 min in the glove box. Then the solution was transferred to the vial containing the substrate 3,4-dihydropyrrolo[1,2-a]pyrazines (0.3 mmol) together with toluene (2.0 mL). The vial was taken to an autoclave and the hydrogenation was conducted at 40. as well as at a hydrogen pressure of 500 psi for 48 h. After carefully releasing the hydrogen, the autoclave was opened and the toluene was evaporated in vacuo. The residue was purified by column chromatography to afford the corresponding chiral tetrahydropyrrolo[1,2-a]pyrazines. |
| WOS关键词 | CATALYZED ASYMMETRIC HYDROGENATION ; FRIEDEL-CRAFTS REACTION ; HETEROAROMATIC-COMPOUNDS ; CYCLIC IMINES ; PROGRESS ; DERIVATIVES |
| WOS研究方向 | Chemistry |
| 语种 | 英语 |
| 出版者 | SCIENCE PRESS |
| WOS记录号 | WOS:000430047400004 |
| 源URL | [http://cas-ir.dicp.ac.cn/handle/321008/169116]  |
| 专题 | 大连化学物理研究所_中国科学院大连化学物理研究所 |
| 通讯作者 | Zhou Yong-Gui |
| 作者单位 | 1.Chinese Acad Sci, Dalian Inst Chem Phys, Dalian 116023, Peoples R China 2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China |
| 推荐引用方式 GB/T 7714 | Chen Mu-Wang,Zhou Yong-Gui,Hu Shu-Bo,et al. Synthesis of Tetrahydropyrrolo/indolo[1,2-a]pyrazines by Enantioselective Hydrogenation of Heterocyclic Imines[J]. ACTA CHIMICA SINICA,2018,76(2):103-106. |
| APA | Chen Mu-Wang,Zhou Yong-Gui,Hu Shu-Bo,&Zhai Xiao-Yong.(2018).Synthesis of Tetrahydropyrrolo/indolo[1,2-a]pyrazines by Enantioselective Hydrogenation of Heterocyclic Imines.ACTA CHIMICA SINICA,76(2),103-106. |
| MLA | Chen Mu-Wang,et al."Synthesis of Tetrahydropyrrolo/indolo[1,2-a]pyrazines by Enantioselective Hydrogenation of Heterocyclic Imines".ACTA CHIMICA SINICA 76.2(2018):103-106. |
入库方式： OAI收割
来源：大连化学物理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。